Full-Time

Senior Manager/Director of Expert Research Solutions

Updated on 6/24/2026

ClearView Healthcare Partners

ClearView Healthcare Partners

501-1,000 employees

Life sciences strategy consulting for biopharma

Compensation Overview

$165k - $215k/yr

+ Bonus

Boston, MA, USA + 1 more

More locations: New York, NY, USA

In Person

On-site in Boston or New York City; relocation not stated.

Category
Consulting (1)
Requirements
  • 8+ years of experience in expert network management, consulting research operations, or other relationship-driven sourcing roles (life sciences or healthcare background preferred)
  • Background in a recruiting or executive search agency is highly transferable, especially experience curating specialized talent pipelines or expert networks.
  • Proven success building curated networks or strategic partnerships that deliver measurable impact.
  • Exceptional interpersonal and negotiation skills; strong brand ambassador presence when interacting with external experts.
  • Experience balancing high‑volume research needs and specialized project sourcing.
  • Demonstrated ability to manage budgets, prioritize investments, and lead small, agile teams.
  • Bachelor’s degree required; advanced degree preferred (MBA, MPH, or related discipline).
Responsibilities
  • Strategic Leadership: Define and execute the ERS vision and roadmap to align with the firm’s primary research and broader consulting priorities.
  • Prioritization and Value Creation: Identify where ERS resources create the highest client value — balancing hard‑to‑recruit segments, specialized expertise, and project scalability
  • Network Curation & Management: Build and maintain a best‑in‑class network of experts spanning payers, KOLs, industry leaders, and niche specialists across therapeutic areas and functional domains. Ensure ongoing engagement and quality collaboration.
  • Team Development: Lead, coach, and grow a small but high‑performing team of researchers and relationship managers, instilling best practices in expert sourcing, vetting, and compliance.
  • Operational Excellence: Oversee P&L, platform partnerships, data management, and network sourcing workflows to ensure efficiency and quality.
  • Cross‑Functional Collaboration: Partner with project leaders to anticipate upcoming needs and shape expert engagement strategies that enhance project outcomes.
  • Market Insight: Track emerging influences and thought leaders across healthcare, life sciences, and market access ecosystems to inform network expansion.
ClearView Healthcare Partners

ClearView Healthcare Partners

View

ClearView Healthcare Partners provides strategic consulting services exclusively for the life sciences sector, guiding pharmaceutical, biotechnology, medical devices, and diagnostics firms through decisions from discovery to commercialization. It completes project work with 100% of a dedicated team focused on a single client engagement, pairing rigorous scientific knowledge with business strategy, with many consultants holding life sciences PhDs. The firm differentiates itself through its strict one-client-per-project model, sector-only focus, and deep scientific expertise, plus international expansion to serve global clients. Its goal is to help life sciences companies grow, advance product development, and secure market access, creating value across the entire product lifecycle.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Newton, Massachusetts

Founded

2008

Your Connections

People at ClearView Healthcare Partners who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Gurgaon office expands Asia-Pacific client reach since 2025.
  • $4M Epistemic AI investment enhances AI-driven biomedical analysis.
  • 330 employees position as largest independent life sciences consultancy.

What critics are saying

  • Founder departures destabilize leadership post-GHO 2021 acquisition.
  • Pharma M&A cuts consulting budgets through 2025.
  • McKinsey life sciences hires poach PhD consultants immediately.

What makes ClearView Healthcare Partners unique

  • 100% project team dedication ensures focused life sciences strategy.
  • Over half consultants hold life sciences PhDs for scientific rigor.
  • Exclusive focus on pharma, biotech, medtech growth strategies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Remote Work Options

Health Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Holidays

Flexible Work Hours

Wellness Program

Mental Health Support

Professional Development Budget

Conference Attendance Budget

Stock Options

Company Equity

Family Planning Benefits

Fertility Treatment Support

Home Office Stipend

Phone/Internet Stipend

Parental Leave

Adoption Assistance

Meal Benefits

Relocation Assistance

Employee Referral Bonus

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Training Programs

Company News

PR Newswire
Mar 12th, 2025
The Addf'S Diagnostics Accelerator Authors New Paper On Ocular Biomarker Landscape, Highlighting Ocular Tests As A Tool For Early Detection Of Alzheimer'S Disease

New findings published in Alzheimer's Dementia suggest blood biomarkers are expected to become the standard method for diagnosing Alzheimer's, while ocular tests offer a non-invasive alternative for detecting at-risk patient populations NEW YORK, March 12, 2025 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation's (ADDF) Diagnostics Accelerator (DxA) authored a first-of-its-kind paper, "Unlocking ocular biomarkers for early detection of Alzheimer's disease," providing a landscape review of ocular biomarkers as another tool, alongside blood biomarkers, to aid in the early detection of Alzheimer's disease. The paper, which was published in Alzheimer's Dementia, shares an informed perspective on the role of ocular biomarkers in the broader Alzheimer's diagnostics space and what defines a true ocular biomarker, while also highlighting the potential for ocular screening to identify at-risk patients who would otherwise go undiagnosed. The authors' assessment is based on hours of in-depth interviews with leading neurologists, ophthalmologists, optometrists, and primary care physicians from across the United States

CityBiz
Jan 13th, 2025
ClearView Invests $4M in Epistemic AI

ClearView Healthcare Partners announced a $4 million minority investment in Epistemic AI to enhance its EpistemicGPT platform, which combines AI with a vast biomedical knowledge graph. This partnership aims to improve ClearView's service offerings by integrating AI technology, enhancing research and drug development processes. The collaboration underscores a commitment to advancing biomedical research and healthcare outcomes through innovative technology solutions.

CityBiz
Jan 13th, 2025
ClearView Healthcare Partners Invest In Epistemic AI

BOSTON, MA and WESTPORT, CT – 13 January 2025: ClearView Healthcare Partners, the leading life sciences strategic consultancy supporting Pharma... Read More

Digital Therapeutics Alliance
Nov 15th, 2023
DTx Commercialization Launch Playbook Case Study

Digital Therapeutics Alliance is thrilled to announce the release of its latest white paper in collaboration with Clearview Healthcare Partners!

Foundation Fighting Blindness
Feb 13th, 2023
The Foundation's long-term impact on moving the inherited retinal disease field forward towards treatments and cures. — Foundation Fighting Blindness

The Foundation Fighting Blindness partnered with ClearView Healthcare Partners to evaluate the impact of its funding and resources since 2005 on the clinical understanding and development of novel therapies for inherited retinal diseases (IRDs).